Tag: NNZ-2591

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to NNZ-2591

Positive FDA meetings enable Neuren to proceed with INDs for three Phase 2 trials

Added to Collection on: 2021-05-31 23:26:15

Tags for this article:

Health
Branches of biology
Neurological disorders
Pharmaceutical industry
Drug discovery
Food and Drug Administration
Angelman syndrome
Clinical trial
22q13 deletion syndrome
Neurodevelopmental disorder
Angelman
Pitt Hopkins
NNZ-2591
United States
Neuren Pharmaceuticals Limited

Click the tags to see associated articles and topics

View Article Details
Neuren Pharmaceuticals (ASX:NEU) receives US patent for NNZ-2591 - The Market Herald

Added to Collection on: 2021-10-11 03:00:00

Tags for this article:

Psychiatric diagnosis
Autism
Causes of autism
Branches of biology
Nervous system
Medical specialties
NNZ-2591
Neuren Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details